# PTPN7

## Overview
PTPN7, or protein tyrosine phosphatase non-receptor type 7, is a gene that encodes a cytoplasmic enzyme involved in the regulation of cellular signaling pathways. The protein product of PTPN7, also known as hematopoietic protein tyrosine phosphatase (HePTP), functions primarily as a phosphatase, modulating the activity of key signaling molecules such as extracellular signal-regulated kinases (ERK1/2) and p38 MAP kinase. This regulation is crucial for maintaining immune homeostasis, particularly in T lymphocytes, where PTPN7 acts as a negative regulator of ERK activation, influencing T-cell activation and immune responses (Kuang2022PTPN2; Inamdar2019The). Beyond its role in the immune system, PTPN7 is expressed in various cell types, including platelets, where it regulates thromboxane A2 generation and platelet activation (Inamdar2019The). Alterations in PTPN7 expression have been implicated in several cancers, highlighting its potential as a prognostic marker and its involvement in oncogenic signaling pathways (Chen2020The).

## Function
PTPN7, also known as protein tyrosine phosphatase non-receptor type 7, is a cytoplasmic enzyme that plays a crucial role in regulating T-cell signaling by dephosphorylating extracellular signal-regulated kinases (ERK1/2) and p38 MAP kinase. This dephosphorylation modulates signaling pathways essential for immune responses, particularly in T lymphocytes (Kuang2022PTPN2; Inamdar2019The). In healthy human cells, PTPN7 acts as a negative regulator of ERK activation, thereby influencing T-cell activation and maintaining immune homeostasis (Kuang2022PTPN2; Liu2023Comprehensive).

PTPN7 is expressed in various cell types, including platelets, where it regulates thromboxane A2 (TXA2) generation, a critical factor in platelet activation and thrombus formation. In platelets, PTPN7 deficiency leads to enhanced ERK activation and increased TXA2 generation, resulting in heightened platelet aggregation and secretion responses (Inamdar2019The). Despite its regulatory role in ERK activation, PTPN7 does not significantly affect other MAPKs or proximal signaling pathways, indicating its specific function in modulating ERK activity (Gronda2001Hematopoietic). This precise regulation is vital for maintaining normal cellular functions and preventing excessive immune or thrombotic responses.

## Clinical Significance
PTPN7, also known as protein tyrosine phosphatase non-receptor type 7, has been implicated in various cancers due to alterations in its expression levels. In digestive tract cancers, such as colorectal cancer (CRC) and stomach adenocarcinoma (STAD), PTPN7 is differentially expressed. High expression of PTPN7 is associated with increased hazards of death in CRC and is correlated with the pathological grade of STAD, suggesting its potential as a prognostic marker (Chen2020The). In colorectal cancer, elevated PTPN7 expression is linked to unfavorable overall survival, indicating its role in cancer progression (Chen2020The).

In pancreatic adenocarcinoma (PAAD), PTPN7 expression is higher in tumor tissues compared to normal tissues, although its correlation with tumor stage is not significant. Despite this, higher PTPN7 expression is associated with poor overall survival and disease-specific survival, though these findings lack statistical significance (Kuang2022PTPN2).

PTPN7 is also involved in the regulation of immune responses, and its dysregulation may contribute to abnormal cell growth and survival in cancers. However, knockout studies in mice suggest that its effects might be compensated by other genes, indicating a complex role in disease mechanisms (Hendriks2023Hereditable).

## Interactions
PTPN7, also known as hematopoietic protein tyrosine phosphatase (HePTP), is involved in several interactions with proteins and nucleic acids that influence cellular signaling pathways. PTPN7 interacts with MAP kinases, such as ERK1/2 and p38, modulating their activity. This interaction is crucial in various cellular processes, including immune responses and cellular communication (Inamdar2019The).

In melanoma cells, PTPN7 is targeted by microRNA-592 (miR-592) contained within extracellular vesicles from melanoma stem cells. This interaction leads to the downregulation of PTPN7, thereby activating the MAPK/ERK signaling pathway, which promotes metastasis (Zhang2022Extracellular). The miR-592/PTPN7 interaction highlights the role of PTPN7 in cancer progression by modulating oncogenic signaling pathways (Zhang2022Extracellular).

In the context of sperm motility, PTPN7 is targeted by piR-121380, a piRNA that regulates the phosphorylation of ERK2. This interaction affects sperm quality and motility, particularly during the cryo-capacitation process. The modulation of ERK2 phosphorylation by piR-121380 through PTPN7 is significant for maintaining sperm function post-thawing (Wang2022piR121380).

In platelets, PTPN7 acts as a negative regulator of ERK activation and thromboxane A2 generation, influencing platelet aggregation and secretion. PTPN7 knockout platelets exhibit increased ERK phosphorylation, indicating its inhibitory role in ERK activation (Inamdar2019The).


## References


[1. (Inamdar2019The) Vaishali V. Inamdar, Haritha Reddy, Carol Dangelmaier, John C. Kostyak, and Satya P. Kunapuli. The protein tyrosine phosphatase ptpn7 is a negative regulator of erk activation and thromboxane generation in platelets. Journal of Biological Chemistry, 294(33):12547–12554, August 2019. URL: http://dx.doi.org/10.1074/jbc.ra119.007735, doi:10.1074/jbc.ra119.007735. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.007735)

[2. (Chen2020The) Jing Chen, Xu Zhao, Yuan Yuan, and Jing-Jing Jing. The expression patterns and the diagnostic/prognostic roles of ptpn family members in digestive tract cancers. Cancer Cell International, June 2020. URL: http://dx.doi.org/10.1186/s12935-020-01315-7, doi:10.1186/s12935-020-01315-7. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-020-01315-7)

[3. (Kuang2022PTPN2) Wenbin Kuang, Xiao Wang, Jiayu Ding, Jiaxing Li, Minghui Ji, Weijiao Chen, Liping Wang, and Peng Yang. Ptpn2, a key predictor of prognosis for pancreatic adenocarcinoma, significantly regulates cell cycles, apoptosis, and metastasis. Frontiers in Immunology, January 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.805311, doi:10.3389/fimmu.2022.805311. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.805311)

[4. (Hendriks2023Hereditable) Wiljan J. A. J. Hendriks, Remco T. P. van Cruchten, and Rafael Pulido. Hereditable variants of classical protein tyrosine phosphatase genes: will they prove innocent or guilty? Frontiers in Cell and Developmental Biology, January 2023. URL: http://dx.doi.org/10.3389/fcell.2022.1051311, doi:10.3389/fcell.2022.1051311. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.1051311)

[5. (Wang2022piR121380) Yihan Wang, Xiang Yuan, Malik Ahsan Ali, Ziyue Qin, Yan Zhang, and Changjun Zeng. Pir-121380 is involved in cryo-capacitation and regulates post-thawed boar sperm quality through phosphorylation of erk2 via targeting ptpn7. Frontiers in Cell and Developmental Biology, January 2022. URL: http://dx.doi.org/10.3389/fcell.2021.792994, doi:10.3389/fcell.2021.792994. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.792994)

[6. (Zhang2022Extracellular) Yuhan Zhang, Yan Chen, Lei Shi, Jie Li, Wenjuan Wan, Bowen Li, Doudou Liu, Xiaoshuang Li, Yuting Chen, Meng Xiang, Hao Chen, Bin Zeng, H. Rosie Xing, and Jianyu Wang. Extracellular vesicles microrna-592 of melanoma stem cells promotes metastasis through activation of mapk/erk signaling pathway by targeting ptpn7 in non-stemness melanoma cells. Cell Death Discovery, October 2022. URL: http://dx.doi.org/10.1038/s41420-022-01221-z, doi:10.1038/s41420-022-01221-z. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-022-01221-z)

[7. (Gronda2001Hematopoietic) Marcela Gronda, Sara Arab, Barbara Iafrate, Haruhiko Suzuki, and Brent W. Zanke. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. Molecular and Cellular Biology, 21(20):6851–6858, October 2001. URL: http://dx.doi.org/10.1128/mcb.21.20.6851-6858.2001, doi:10.1128/mcb.21.20.6851-6858.2001. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.21.20.6851-6858.2001)

[8. (Liu2023Comprehensive) Yong Liu, Jing Zhang, Zefan Du, Junbin Huang, Yucai Cheng, Wenfang Yi, Tianwen Li, Jing Yang, and Chun Chen. Comprehensive analysis of ptpn family expression and prognosis in acute myeloid leukemia. Frontiers in Genetics, January 2023. URL: http://dx.doi.org/10.3389/fgene.2022.1087938, doi:10.3389/fgene.2022.1087938. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.1087938)